Effect of BrainPhyt High Dose on Cognitive Function in Healthy Older Individuals

Inclusion criteria

• Be able to give written informed consent and to consume the investigational product daily for the duration of the study.
• Healthy males and females aged ≥ 55 and ≤ 75 years old.
• Body-mass index between 18.5 and 35.0 kg/m2
• Is free-living (living in a private home, alone or with family, and able to maintain their health and hygiene without assistance).
• Have age-associated memory impairment (AAMI) based on the following National Institute of Mental Health criteria, specified as scoring:

• Absence of dementia as determined by a score of >24 on the Mini Mental State Examination (MMSE).
• ≤29 or ≤9 on the VPA I and II portions of the Wechsler Memory Scale IV, respectively
• A score on the MAC-Q of ≥25.
• Is in general good health, as determined by the investigator
• Ability to comply and understand the cognitive function practice tests
• Willing to maintain their habitual diet and exercise routines.
• Willing to maintain consistent sleep duration the evening before study visits.

Exclusion criteria

• Use of medications or supplements known to alter cognitive function within past 2 weeks
• Abnormal clinical laboratory test that may affect study outcome.
• History or presence of clinically important cardiac, renal, hepatic, endocrine, pulmonary, biliary, gastrointestinal, pancreatic, or neurological disorders (including sleep disorders, head injuries, Alzheimer's disease, Parkinson's disease, stroke, inflammatory brain disease
• History or presence of cancer, except nonmelanoma skin cancer
• Uncontrolled hypertension/diabetes
• History of depression within past 24 months or use of psychotropic medications within 1 month of screening
• Planned major changes in lifestyle (i.e. diet, dieting, exercise level, travelling) during the duration of the study.
• History within previous 12 months of alcohol or substance abuse.
• History of heavy smoking (>1 pack/day) within past 3 months